HealthEquity, Inc. (NASDAQ:HQY) Director Frank Medici sold 316,644 shares of the company’s stock in a transaction on Monday, October 9th. The shares were sold at an average price of $51.96, for a total transaction of $16,452,822.24. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Frank Medici also recently made the following trade(s):
- On Thursday, July 13th, Frank Medici sold 131,800 shares of HealthEquity stock. The shares were sold at an average price of $51.42, for a total transaction of $6,777,156.00.
- On Wednesday, July 12th, Frank Medici sold 332,511 shares of HealthEquity stock. The shares were sold at an average price of $51.13, for a total transaction of $17,001,287.43.
- On Friday, July 14th, Frank Medici sold 537,102 shares of HealthEquity stock. The shares were sold at an average price of $51.24, for a total transaction of $27,521,106.48.
Shares of HealthEquity, Inc. (HQY) opened at 51.39 on Friday. The firm has a market capitalization of $3.11 billion, a PE ratio of 76.25 and a beta of 1.80. HealthEquity, Inc. has a 12-month low of $30.34 and a 12-month high of $54.95. The company has a 50-day moving average of $46.90 and a 200 day moving average of $46.77.
HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Tuesday, September 5th. The company reported $0.27 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.13. The business had revenue of $56.90 million for the quarter, compared to the consensus estimate of $55.66 million. HealthEquity had a net margin of 20.27% and a return on equity of 13.93%. HealthEquity’s quarterly revenue was up 28.7% on a year-over-year basis. During the same quarter last year, the company posted $0.16 earnings per share. On average, analysts predict that HealthEquity, Inc. will post $0.71 EPS for the current year.
Several analysts recently issued reports on HQY shares. TheStreet raised shares of HealthEquity from a “c” rating to a “b” rating in a report on Monday, July 31st. Oppenheimer Holdings, Inc. reaffirmed a “buy” rating and issued a $61.00 price target on shares of HealthEquity in a report on Wednesday, September 6th. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $56.00 price target on shares of HealthEquity in a report on Tuesday, September 5th. Zacks Investment Research raised shares of HealthEquity from a “hold” rating to a “buy” rating and set a $54.00 price target on the stock in a report on Wednesday, July 12th. Finally, Robert W. Baird reaffirmed a “hold” rating on shares of HealthEquity in a report on Thursday, September 21st. Two investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. HealthEquity presently has a consensus rating of “Buy” and a consensus price target of $57.17.
A number of hedge funds have recently modified their holdings of HQY. Fifth Third Bancorp lifted its position in HealthEquity by 382.8% in the first quarter. Fifth Third Bancorp now owns 2,414 shares of the company’s stock worth $102,000 after purchasing an additional 1,914 shares during the period. Oppenheimer Asset Management Inc. bought a new position in HealthEquity in the first quarter worth $106,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its position in HealthEquity by 105.8% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,544 shares of the company’s stock worth $127,000 after purchasing an additional 1,308 shares during the period. Riverhead Capital Management LLC lifted its position in HealthEquity by 75.3% in the second quarter. Riverhead Capital Management LLC now owns 2,629 shares of the company’s stock worth $131,000 after purchasing an additional 1,129 shares during the period. Finally, Exane Derivatives bought a new position in HealthEquity in the second quarter worth $132,000. 90.97% of the stock is owned by hedge funds and other institutional investors.
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with MarketBeat.com's FREE daily email newsletter.